Triple therapy in idiopathic pulmonary fibrosis: an alarming press release

Eur Respir J. 2012 Apr;39(4):805-6. doi: 10.1183/09031936.00009112.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Acetylcysteine / administration & dosage*
  • Acetylcysteine / adverse effects
  • Azathioprine / administration & dosage*
  • Azathioprine / adverse effects
  • Drug Therapy, Combination / adverse effects
  • Expectorants / administration & dosage
  • Expectorants / adverse effects
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / adverse effects
  • Humans
  • Idiopathic Pulmonary Fibrosis / drug therapy*
  • Idiopathic Pulmonary Fibrosis / mortality*
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Prednisolone / administration & dosage*
  • Prednisolone / adverse effects

Substances

  • Expectorants
  • Glucocorticoids
  • Immunosuppressive Agents
  • Prednisolone
  • Azathioprine
  • Acetylcysteine